Pharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...

Strides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene ...

This follows the abbreviated quality system inspection technique drug pre-approval on-site inspection specifically conducted by the US Food...

In the letter written on May 13, Arun Kumar, Founder and Director of Stelis Biopharma Limited, said that after the prime minister had reque...

Sputnik Light is a single dose vaccine. Stelis partnered with Russia's sovereign wealth fund RDIF to produce and supply the Russian Sputnik...

Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...

With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the ...

SII had applied to the Drug Controller General of India (DCGI) seeking permission for a test licence to manufacture Sputnik V, which is bei...

The RDIF has signed agreements with several companies to manufacture Sputnik V in India — Virchow Biotech (up to 200 million doses per year...

Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and He...

The company had posted a net profit of Rs 92.33 crore for the corresponding period of the previous fiscal, Strides Pharma Science said in a...

Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the...

The company's board has approved an additional investment up to a maximum of USD 40 million over a period of 24 months for a controlling st...

This was one of the five greenfield projects the high-level committee headed by chief minister Siddaramaiah cleared on Wednesday.

Stelis Biopharma, wholly-owned arm of Strides Arcolab, has commenced construction of its Rs 370 crore (USD 60 million) biologics facility a...

Strides has so far invested $16.9 million in Stelis. The duo will invest $61.9 million taking total equity investment in Stelis to $78.8 mi...

Stelis Biopharma, a subsidiary of Bangalore-based Strides Arcolab Ltd, said it has entered into a long-term agreement with Germany's Pieris...